Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6492 stock hub

TPEX/6492 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/6492is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
4.6B
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/6492
In the news

Latest news · TPEX/6492

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/En/a
P25 14.4P50 18P75 31.9
ROE-29.6
P25 -16.2P50 0.3P75 9.8
ROIC-19.1
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/6492 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
173
Groups with data
11
Currency
TWD
Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
Taiwan
Country code
TW
Enterprise value
TWD 3.8B
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Biotechnology
Isin
TW0006492002
Last refreshed
2026-05-10
Market cap
TWD 4.6B
Price
TWD 51.4
Price currency
TWD
Sector
Healthcare
Sic
2836
Symbol
tpex/6492
Website
https://www.senhwabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

6
MetricValue
Earnings Yield
-5.76%
EV Earnings
-14.52x
EV/FCF
-15.46x
FCF yield
-5.41%
P/B ratio
6.04x
P/S ratio
4,293.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
Gross margin
48.6%
Gross Profit
TWD 520,000
Gross Profit Growth
9.01%
Gross Profit Growth Q
-24.53%
Gross Profit Growth3 Y
0.98%
Gross Profit Growth5 Y
8.18%
Net Income
TWD -264.8M
Net Income Growth Years
3%
Pretax Margin
-24,620.19%
ROA
-18.45
Roa5y
-13.76
ROCE
-35.95
ROE
-29.62
Roe5y
-21.95
ROIC
-19.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr10y
-9%
Cagr1y
60.93%
Cagr3y
-0.64%
Cagr5y
-17.44%
EPS Growth Years
3
Revenue Growth
7x
Revenue Growth Q
-4x
Revenue Growth Years
1x
Revenue Growth3 Y
2.28x
Revenue Growth5 Y
11.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
TWD 0
Assets
TWD 819.3M
Cash
TWD 771.8M
Current Assets
TWD 780.4M
Current Liabilities
TWD 45.3M
Debt
TWD 22.1M
Debt Equity
TWD 0.03
Debt FCF
TWD -0.09
Equity
TWD 761M
Interest Coverage
-369.5
Liabilities
TWD 58.3M
Long Term Assets
TWD 38.9M
Long Term Liabilities
TWD 13M
Net Cash
TWD 749.7M
Net Cash By Market Cap
TWD 16.32
Net Cash Growth
-25.85%
Net Debt Equity
TWD -0.99
Tangible Book Value
TWD 760.9M
Tangible Book Value Per Share
TWD 8.51
WACC
9.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
17.21
Net Working Capital
TWD -27.6M
Quick ratio
17.02
Working Capital
TWD 735.1M
Working Capital Turnover
TWD 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-61.03%
1Y total return
60.88%
200-day SMA
44.32
3Y total return
-1.91%
50-day SMA
51.74
50-day SMA vs 200-day SMA
50over200
5Y total return
-61.64%
All Time High
309.5
All Time High Change
-83.39%
All Time High Date
2020-09-11
All Time Low
28.45
All Time Low Change
80.67%
All Time Low Date
2025-04-09
ATR
2.15
Beta
0.97
Beta1y
0.57
Beta2y
0.57
Ch YTD
16.82
High
52.4
High52
66.5
High52 Date
2026-02-03
High52ch
-22.71%
Low
50
Low52
32
Low52 Date
2025-06-23
Low52ch
62.15%
Ma50ch
-0.66%
Price vs 200-day SMA
15.98%
RSI
49.19
RSI Monthly
52.65
RSI Weekly
55.1
Sharpe ratio
1.13x
Sortino ratio
2.15
Total Return
-0.03%
Tr YTD
16.82
Tr1m
5.76%
Tr1w
1.38%
Tr3m
-5.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
TWD -278.3M
Operating margin
-26,005.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
69,013,451%
Net Borrowing
-9,343,000
Shares Insiders
2.04%
Shares Institutions
0.1%
Shares Out
89,386,000
Shares Qo Q
0.12%
Shares Yo Y
0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

53
MetricValue
Adjusted FCF
TWD -249.9M
Average Volume
406,781.2x
Bv Per Share
8.51
CAPEX
TWD -280,000
Ch10y
-61.87
Ch1m
5.76
Ch1w
1.38
Ch1y
60.88
Ch3m
-5.86
Ch3y
-1.91
Ch5y
-61.64
Ch6m
14.6
Change
-1.15%
Change From Open
-1.91
Close
52
Days Gap
0.77
Depreciation Amortization
2,177,000
Dollar Volume
21,203,682.2
Earnings Date
2026-05-12
EBIT
TWD -278.3M
EBITDA
TWD -276.1M
EPS
TWD -2.97
F Score
3
FCF
TWD -248.7M
FCF EV Yield
-6.47x
FCF Per Share
TWD -2.78
Financing CF
-9,343,000
Fiscal Year End
December
Founded
2,012
Income Tax
TWD 1.3M
Investing CF
5,816,000
Is Primary Listing
1
Last Earnings Date
2025-11-10
Last Report Date
2025-12-31
Ma150
47.16
Ma150ch
9%
Ma20
51.98
Ma20ch
-1.12%
Net CF
-254,188,000
Next Earnings Date
2026-05-12
Open
52.4
Position In Range
58.33
Ppne
22,827,000
Price Date
2026-05-08
Ptbv Ratio
6.04
Relative Volume
1x
Revenue
1,070,000x
SBC By Revenue
107.76x
Share Based Comp
1,153,000
Tax By Revenue
124.58x
Tr6m
14.6%
Volume
412,523
Z Score
35.02
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TPEX/6492 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6492 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+60.9%
S&P 500 1Y: n/a
3Y total return
-1.9%
S&P 500 3Y: n/a
5Y total return
-61.6%
S&P 500 5Y: n/a
10Y total return
-61.0%
S&P 500 10Y: n/a
Ownership

Who owns TPEX/6492?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.1%
Share of float held by funds and institutions
Insider ownership
+2.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

TPEX/6492 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.2
Neutral momentum band
Price vs 200-day MA
+16.0%
50/200-day relationship not available
Beta (5Y)
0.97
Moves roughly with the market
Sharpe ratio
1.13
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/6492

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6492 stock rating?

tpex/6492 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6492 analysis?

The full report lives at /stocks/tpex/6492/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6492?

The latest report frames tpex/6492 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6492 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.